-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HfwwH4xo6T+kBwuWPIu6+o1CKsbBsItUjwtHZiA16Hz6pN8MZ+wVaJdPBYDcagUe aDBct+Re6l2EhKTpPmdX+w== 0001144204-10-021330.txt : 20100420 0001144204-10-021330.hdr.sgml : 20100420 20100420163713 ACCESSION NUMBER: 0001144204-10-021330 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100420 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20100420 DATE AS OF CHANGE: 20100420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RENHUANG PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000926844 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 881273503 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24512 FILM NUMBER: 10759700 BUSINESS ADDRESS: STREET 1: NO. 281, TAIPING ROAD, TAIPING DISTRICT STREET 2: HARBIN, HEILONGJIANG PROVINCE, CITY: PEOPLES REPUBLIC OF STATE: F4 ZIP: 150050 BUSINESS PHONE: 86-451-5762-0378 MAIL ADDRESS: STREET 1: NO. 281, TAIPING ROAD, TAIPING DISTRICT STREET 2: HARBIN, HEILONGJIANG PROVINCE, CITY: PEOPLES REPUBLIC OF STATE: F4 ZIP: 150050 FORMER COMPANY: FORMER CONFORMED NAME: ANZA CAPITAL INC DATE OF NAME CHANGE: 20020521 FORMER COMPANY: FORMER CONFORMED NAME: E-NET FINANCIAL COM CORP DATE OF NAME CHANGE: 20000317 FORMER COMPANY: FORMER CONFORMED NAME: E-NET COM CORP DATE OF NAME CHANGE: 20000127 8-K 1 v181664_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K
 
 
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 20, 2010
 
 
RENHUANG PHARMACEUTICALS, INC.
(Exact name of Registrant as Specified in its Charter)
 
 
Nevada
  
0-24512
  
88-1273503
(State or Other Jurisdiction
of Incorporation)
  
(Commission File Number)
  
(IRS Employer
Identification No.)

No. 281, Taiping Road, Taiping District
Harbin, Heilongjiang Province, 150050
(Address of Principal Executive Offices)

Registrant’s telephone number, including area code:  86-451-5762-0378

N/A
(Former Name or Former Address, if Changed Since Last Report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

(d)           On April 20, 2010, Renhuang Pharmaceuticals, Inc. (the “Company”) appointed Mr. Changxiong Sun, age 65, as a member of the Board of Directors of the Company.  Mr. Sun will serve as an independent director and the Chairman of the Nominations Committtee of the Board of Directors.  Since 2005 Mr. Sun has served as a Professor and Doctoral Tutor at the Management College of Harbin Institute of Technology. Since 2005 Mr. Sun has served as the Executive Director of the Overseas Development and Layout Association of China Industry.  Since 2005 Mr. Sun has served as the Director of the Heilongjiang Dongbeiya Economy and Technology Committee.  From 2004 to 2005, Mr. Sun served as the Vice Secretary General of the Harbin Municipal Government Committee.  From 1999 to 2004, Mr. Sun served as the Director of the Harbin Finance Management Department.  Mr. Sun has a degree in Management Science and Engineering from the Harbin Institute of Technology.

The Company has agreed to pay Mr. Sun an annual fee of RMB 36,000, payable on a monthly basis, for his service on the Board of Directors and as the Chairman of the Nominations Committee of the Board of Directors.

On April 20, 2010, Renhuang Pharmaceuticals, Inc. (the “Company”) appointed Mr. Bingchun Wu, age 73, as a member of the Board of Directors of the Company.  Mr. Wu will serve as an independent director and the Chairman of the Compensation Committtee of the Board of Directors.  Since 2006 Mr. Wu has served as the Team Leader of the Chinese Medicine Research Group at the Heilongjiang Province Chinese Medicine Research Institute.  From 2006 to 2007, Mr. Wu served as the Chief Expert of the Chinese Medicine Group of the Innovation System of Heilongjiang Province Science and Technology Department.  From 2004 to 2006, Mr. Wu served as the Director of the Chinese Pharmacology Research Office and the Head of Chinese Medicine Resaerch at the Heilongjiang Province Science and Technology Department.  Mr. Wu has a degree in Pharmaceutical Science from Shenyang Medicine University and a bachelor degree in Financial Management from Harbin University of Commerce.

The Company has agreed to pay Mr. Wu an annual fee of RMB 36,000, payable on a monthly basis, for his service on the Board of Directors and as the Chairman of the Compensation Committee of the Board of Directors.



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
RENHUANG PHARMACEUTICALS, INC.
     
Date: April 20, 2010
  
By:
  
/s/ Shaoming Li
       
Shaoming Li
       
Chief Executive Officer
 
 -----END PRIVACY-ENHANCED MESSAGE-----